Aim: The objective of this study extension was to determine if the reduction in waist circumference previously achieved in 6 months, in order to normalise cardiometabolic risk, could be maintained beyond 12 additional months.
Method: Patients who had participated previously in a nutritional intervention including a medical nutrition product (Stablor®) were followed for at least 12 months after suspension of this nutritional care.
Result: The 29 participants maintained an average reduction of 4.2% in waist circumference 22 months on the average after the initial assessment.
Conclusion: A reduction in waist circumference achieved due to a nutritional intervention combining a medical nutrition product and calorie restriction is sustainable more than one year after the end of this intervention and remains below the threshold of cardiometabolic risk for the vast majority of patients.

Keyword: waist circumference, nutritional intervention, diet, visceral fat, cardiometabolic risk, metabolic syndrome, weight maintenance, glycaemia

• Full Text: PDF(303.93KB)
• Full Text: HTML